Designs of two randomized, community-based trials to assess the impact of influenza immunization during pregnancy on respiratory illness among pregnant women and their infants and reproductive outcomes in rural Nepal

James M Tielsch, Mark Steinhoff, Joanne Katz, Janet A Englund, Jane Kuypers, Subarna K Khatry, Laxman Shrestha, Steven C LeClerq, James M Tielsch, Mark Steinhoff, Joanne Katz, Janet A Englund, Jane Kuypers, Subarna K Khatry, Laxman Shrestha, Steven C LeClerq

Abstract

Background: Among the most important causes of illness and death in both pregnant women and their newborn infants are respiratory infections including influenza. Pregnant women in North America have a 4 to 5 fold excess rate of hospitalization compared to non-pregnant women. Rates of infant hospitalization associated with influenza are much higher than in their mothers. Fully half of children hospitalized for influenza in the US are in the age group 0-5 months, a group where no vaccine is licensed. Data on influenza are much fewer in low income countries where the risks of serious morbidity and mortality are much higher. A recent trial in Bangladesh suggested that influenza immunization in pregnant women could have important protective effects against influenza in both mothers and their infants. These trials were designed to provide additional evidence about the effect of influenza vaccination in pregnancy in settings where influenza may circulate for up to ten months/year.

Methods/design: We conducted a consecutive pair of community-based, placebo-controlled, randomized trials of influenza vaccination of pregnant women in a rural district in southern Nepal. Two trials were conducted to insure, as much as possible, the match of circulating strains with those included in the vaccine. Eligible women included all who were or became pregnant over a one year period. Each trial included a one year cohort of pregnant women who were individually randomized to the influenza vaccine available at the time of their enrollment or placebo. Exclusions included a history of allergy to vaccine components, prior influenza vaccine receipt, and for the second trial, participation in the first trial. Morbidity was assessed on a weekly basis for women throughout pregnancy and through 180 days post-partum. Infants were followed weekly through 180 days. Primary outcomes included: 1) incidence of influenza like illness in women, 2) incidence of laboratory confirmed influenza illness in infants, and 3) birthweight among newborn infants.

Discussion: We have presented the design and methods of two randomized trials of influenza immunization of pregnant women.

Trial registration: Clinicaltrials.gov: ( NCT01034254 ).

References

    1. Ortiz J, Englund JA, Neuzil KM. Influenza vaccine for pregnant women in resource-constrained countries: a review of the evidence to inform policy decisions. Vaccine. 2011;29:4439–4452. doi: 10.1016/j.vaccine.2011.04.048.
    1. Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, Anderson LJ, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA. 2003;289(2):179–186. doi: 10.1001/jama.289.2.179.
    1. Irving WL, James DK, Stephenson T, Laing P, Jameson C, Oxford JS, Chakraverty P, Brown DW, Boon AC, Zambon MC. Influenza virus infection in the second and third trimesters of pregnancy: a clinical and seroepidemiological study. BJOG. 2000;107(10):1282–1289. doi: 10.1111/j.1471-0528.2000.tb11621.x.
    1. Shahab SZ, Glezen WP. Influenza virus. In: Gonik B, editor. Viral disease in pregnancy. New York NY: Springer Verlag; 1994. pp. 215–223.
    1. Freeman DW, Barno A. Deaths from Asian influenza associated with pregnancy. Am J Obstet Gynecol. 1959;78:1172–1175.
    1. Creanga AA, Johnson TF, Graitcer DB, Hartman LK, Al-Samarrai T, Schwarz AG, Chu SY, Sackoff JE, Jamieson DJ, Fine AD, Shapiro-Mendoza CK, Jones LE, Uyeki TM, Balter S, Bish CL, Finelli L, Honein MA. Severity of 2009 pandemic influenza A (H1N1) virus infection in pregnant women. Obstet Gynecol. 2010;115:717–726. doi: 10.1097/AOG.0b013e3181d57947.
    1. Munoz FM, Englund JA. Vaccines in pregnancy. Infect Dis Clin North Am. 2001;15(1):253–271. doi: 10.1016/S0891-5520(05)70278-6.
    1. Centers for Disease Control and Prevention (CDC) Maternal and infant outcomes among severely ill pregnant and postpartum women with 2009 pandemic influenza A (H1N1)--United States, April 2009-August 2010. MMWR Morb Mortal Wkly Rep. 2011;60:1193–1196.
    1. Neuzil KM, Reed GW, Mitchel EF, Simonsen L, Griffin MR. Impact of influenza on acute cardiopulmonary hospitalizations in pregnant women. Am J Epidemiol. 1998;148:1094–1102. doi: 10.1093/oxfordjournals.aje.a009587.
    1. Dodds L, McNeil SA, Fell DB, Allen VM, Coombs A, Scott J, MacDonald N. Impact of influenza exposure on rates of hospital admissions and physician visits because of respiratory illness among pregnant women. CMAJ. 2007;176(4):463–468. doi: 10.1503/cmaj.061435.
    1. McNeil SA, Dodds L, Allen VM, Scott J, Halperin B, MacDonald N. Influenza vaccine programs and pregnancy: new Canadian evidence for immunization. J Obstet Gynaecol Can. 2007;29(8):674–676.
    1. Mak TK, Mangtani P, Leese J, Watson JM, Pfeifer D. Influenza vaccination in pregnancy: current evidence and selected national policies. Lancet Infect Dis. 2008;8:44–52. doi: 10.1016/S1473-3099(07)70311-0.
    1. Cox S, Posner SF, McPheeters M, Jamieson DJ, Kourtis AP, Meikle S. Hospitalizations with respiratory illness among pregnant women during influenza season. Obstet Gynecol. 2006;107:1315–1322. doi: 10.1097/.
    1. Poehling KA, Edwards KM, Weinberg GA, Szilaqyi P, Staat MA, Iwane MK, et al. The underrecognized burden of influenza in young children. N Engl J Med. 2006;355(1):31–40. doi: 10.1056/NEJMoa054869.
    1. Coffin SE, Zaoutis TE, Rosenquist AB, Heydon K, Herrera G, Bridges CB, Watson B, Localio R, Hodinka RL, Keren R. Incidence, complications, and risk factors for prolonged stay in children hospitalized with community-acquired influenza. Pediatrics. 2007;119(4):740–748. doi: 10.1542/peds.2006-2679.
    1. Greenwood B. Maternal immunization in developing countries. Vaccine. 2003;21:3436–3441. doi: 10.1016/S0264-410X(03)00346-3.
    1. Darmstadt GL, Bhutta ZA, Cousens S, Adam T, Walker N, de BL. Evidence-based, cost-effective interventions: how many newborn babies can we save? Lancet. 2005;365:977–988. doi: 10.1016/S0140-6736(05)71088-6.
    1. Zaman K, Roy E, Arifeen SE, Rahman M, Raqib R, Wilson E, Omer SB, Shahid N, Breiman R, Steinhoff MC. Effectiveness of maternal influenza immunization in mothers and infants. N Engl J Med. 2008;359:1555–1564. doi: 10.1056/NEJMoa0708630.
    1. Steinhoff MC, Omer SB, Roy E, El Arifeen S, Raqib R, Dodd C, Breiman RF, Zaman K. Neonatal outcomes after influenza immunization during pregnancy: a randomized controlled trial. CMAJ. 2012;184(6):645–653. doi: 10.1503/cmaj.110754.
    1. Intensive Study and Research Center Pvt., Ltd . District and VDC Profile of Nepal – 2014/15. Kathmandu: BookArt Nepal; 2014.
    1. Papageorghiou AT, Kennedy SH, Salomon LJ, Ohuma EO, Ismail LC, Barros FC, et al. International standards for early fetal size and dating based on ultrasound measurement of crown-rump length in the first trimester. Ultrasound Obstet Gynecol. 2014 Jul 8. doi:10.1002/uog.13448.
    1. World Health Organization . WHO Child Growth Standards: Methods and development: Length/height-for-age, weight-for-age, weight-for-length, weight-for-height and body mass index-for-age: methods and development. Geneva: World Health Organization; 2006.
    1. Kuypers J, Wright N, Corey L, Morrow R. Detection and quantification of human metapneumovirus in pediatric specimens by real-time RT-PCR. J Clin Virol. 2005;33(4):299–305. doi: 10.1016/j.jcv.2004.11.023.
    1. Kuypers J, Wright N, Ferrenberg J, Huang ML, Cent A, Corey L, et al. Comparison of real-time PCR assays with fluorescent-antibody assays for diagnosis of respiratory virus infections in children. J Clin Microbiol. 2006;44(7):2382–2388. doi: 10.1128/JCM.00216-06.
    1. Qin X, Galanakis E, Martin ET, Englund JA. Multitarget PCR for diagnosis of pertussis and its clinical implications. J Clin Microbiol. 2007;45:506–511. doi: 10.1128/JCM.02042-06.
    1. Lu Y, Jacobson DL, Ashworth LA, Grand RJ, Meyer AL, McNeal MM, Gregas MC, Burchett SK, Bousvaros A. Immune response to influenza vaccine in children with inflammatory bowel disease. Am J Gastroenterol. 2009;104:444–453. doi: 10.1038/ajg.2008.120.
    1. Treanor JJ, Schiff GM, Hayden FG, Brady RC, Hay CM, Meyer AL, Holden-Wiltse J, Liang H, Gilbert A, Cox M. Safety and immunogenicity of a baculovirus-expressed hemagglutinin influenza vaccine: a randomized controlled trial. JAMA. 2007;297:1577–1582. doi: 10.1001/jama.297.14.1577.
    1. WHO Global Influenza Surveillance Network . Manual for the laboratory diagnosis and virological surveillance of influenza. Geneva: World Health Organization, WHO Press, World Health Organization; 2011.
    1. Katz JM, Hancock K, Xu X. Serologic assays for influenza surveillance, diagnosis and vaccine evaluation. Expert Rev Anti Infect Ther. 2011;9:669–683. doi: 10.1586/eri.11.51.
    1. Mullany LC, Darmstadt GL, Khatry SK, Katz J, LeClerq SC, Shrestha SR, Adhikari R, Tielsch JM. Topical applications of chlorhexidine to the umbilical cord for prevention of omphalitis and neonatal mortality in southern Nepal: a community-based, cluster-randomised trial. Lancet. 2006;367:910–918. doi: 10.1016/S0140-6736(06)68381-5.
    1. Tielsch JM, Darmstadt GL, Mullany LC, Khatry SK, Katz J, LeClerq SC, Shresta S, Adhikari R. Impact of newborn skin cleansing with chlorhexidine on neonatal mortality in southern Nepal: a community-based, cluster-randomized trial. Pediatrics. 2007;119(2):e330–340. doi: 10.1542/peds.2006-1192.

Source: PubMed

Patrocinadores e Colaboradores

Condições médicas

Intervenções de drogas

3
Se inscrever